Literature DB >> 1922343

Antibiotic inhibition of group I ribozyme function.

U von Ahsen1, J Davies, R Schroeder.   

Abstract

The discovery of catalytically active RNA has provided the basis for the evolutionary concept of an RNA world. It has been proposed that during evolution the functions of ancient catalytic RNA were modulated by low molecular weight effectors, related to antibiotics, present in the primordial soup. Antibiotics and RNA may have coevolved in the formation of the modern ribosome. Here we report that a set of aminoglycoside antibiotics, which are known to interact with the decoding region of the 16S ribosomal RNA of Escherichia coli, inhibit the second step of splicing of the T4 phage-derived td intron. Thus catalytic RNA seems to interact not only with a mononucleotide and an amino acid, but also with another class of biomolecules, the sugars. Splicing of other group I introns but not group II introns was inhibited. The similarity in affinity and specificity of these antibiotics for group I introns and rRNAs may result from recognition of evolutionarily conserved structures.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922343     DOI: 10.1038/353368a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  67 in total

Review 1.  Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance.

Authors:  L P Kotra; J Haddad; S Mobashery
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

2.  Folding of the group I intron ribozyme from the 26S rRNA gene of Candida albicans.

Authors:  Y Zhang; M J Leibowitz
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

3.  Inhibition of RNase P RNA cleavage by aminoglycosides.

Authors:  N E Mikkelsen; M Brännvall; A Virtanen; L A Kirsebom
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

4.  Inhibition of protein synthesis by aminoglycoside-arginine conjugates.

Authors:  Marjolaine Carriere; Veerappan Vijayabaskar; Drew Applefield; Isabelle Harvey; Philippe Garneau; Jon Lorsch; Aviva Lapidot; Jerry Pelletier
Journal:  RNA       Date:  2002-10       Impact factor: 4.942

5.  Effect of peptidyltransferase inhibitors on ribonuclease P activity from Dictyostelium discoideum. Effect of antibiotics on RNase P.

Authors:  C Stathopoulos; A Tsagla; A Tekos; D Drainas
Journal:  Mol Biol Rep       Date:  2000-06       Impact factor: 2.316

6.  Using pyrene-labeled HIV-1 TAR to measure RNA-small molecule binding.

Authors:  Kenneth F Blount; Yitzhak Tor
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

7.  A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.

Authors:  Indrajit Das; Jérôme Désiré; Dinesh Manvar; Isabelle Baussanne; Virendra N Pandey; Jean-Luc Décout
Journal:  J Med Chem       Date:  2012-06-22       Impact factor: 7.446

Review 8.  Antibiotics and evolution: food for thought.

Authors:  C R Strachan; J Davies
Journal:  J Ind Microbiol Biotechnol       Date:  2015-11-02       Impact factor: 3.346

9.  Yeast glycosylation mutants are sensitive to aminoglycosides.

Authors:  N Dean
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

10.  The pseudodisaccharides: a novel class of group I intron splicing inhibitors.

Authors:  J Rogers; J Davies
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.